Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide (NOA-04)
NOA-04 Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
Sponsor: Charite University, Berlin, Germany
This PHASE3 trial investigates Anaplastic Astrocytoma and Oligoastrocytoma and is currently completed. Charite University, Berlin, Germany leads this study, which shows 5 recorded versions since 1999 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jun 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Charite University, Berlin, Germany
- German Cancer Research Center
- Heidelberg University
- Heinrich-Heine University, Duesseldorf
- Neuro-Oncology Working Group of the German Cancer Society
- University Hospital Tuebingen
- University Hospital, Bonn
- University Hospital, Essen
- University of Leipzig
- University of Zurich
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aschaffenburg, Germany , Bamberg, Germany , Berlin, Germany , Düsseldorf, Germany , Erlangen, Germany , Essen, Germany , Frankfurt, Germany , Heidelberg, Germany , Kiel, Germany , Mainz, Germany and 2 more locations